$GMAB · Genmab A/S Congress Trades

Rep. Josh Gottheimer (NJ-05) executed extensive trading activity in January 2025 through a Morgan Stanley managed account, with over 100 transactions involving purchases and sales across a diversified portfolio of blue-chip stocks, technology companies, and international equities. Most transactions ranged from $1,001-$15,000, with one notable sale of Merck & Company (MRK) in the $15,001-$50,000 range on January 27, 2025.

Rep. Josh Gottheimer (NJ-05) executed a diverse portfolio of transactions in December 2024, including significant options activity on Microsoft (MSFT) with multiple call option sales and purchases ranging from $1,000,001-$5,000,000, along with numerous stock purchases and sales across major companies including Apple, Goldman Sachs, Johnson & Johnson, Walmart, and Tesla, with most individual stock transactions in the $1,001-$15,000 range.

Rep. Josh Gottheimer (NJ-05) executed 73 stock transactions during July 2024 across a diversified portfolio managed through Morgan Stanley accounts, with transaction amounts ranging from $1,001-$15,000 each. The activity included purchases and partial sales of major tech stocks (Tesla, Meta, Netflix, Alphabet), financial services (Mastercard, Block), healthcare (Eli Lilly, Regeneron, AtriCure), industrial (Northrop Grumman, D.R. Horton), and international equities.

Hon. Josh Gottheimer conducted extensive portfolio rebalancing in June 2024, executing numerous sales (predominantly partial positions) across a diversified portfolio of domestic and international stocks worth $1,001-$15,000 each, while making selective purchases in Apple (AAPL), Broadcom (AVGO), Grupo Financiero Banorte (GBOOY), Intuitive Surgical (ISRG), Microsoft (MSFT), NVIDIA (NVDA), and Advanced Energy Industries (AEIS).